F-MELACLEAR

F-MELACLEAR targets melasma and localized dark spots through a synergy of brightening actives. Tranexamic acid, the main component, inhibits UV-induced plasmin activity in keratinocytes, decreasing tyrosinase activity in melanocytes; it works with arbutin to inhibit tyrosinase, while glutathione brightens by converting melanin into a lighter form, niacinamide soothes inflammation and regulates melanin production, and resorcinol provides gentle exfoliation and cellular renewal. Its efficacy is supported by clinical studies on tranexamic acid mesotherapy showing significant reduction in melasma severity and skin-lightening effects. Daily use of Meso Shield 50 each morning is recommended, and caution is advised when treating the entire face to avoid over-lightening.

Recommended for you: F-VITAMIN C

• Treatment for melasma.
• Reduce localized dark spots.

Apply via meso-needling, transdermal delivery devices, or post laser on face, neck, and décolleté. Use 1 to 3 ml per treatment (face and neck) with the nappage technique, targeting the epidermis (melanocytes). Initial course of 5 to 8 treatments with 2 weeks between sessions, then one treatment every 6 weeks as maintenance. Use daily Meso Shield 50 each morning; apply with caution on the entire face to avoid over-lightening.

• Niacinamide — Soothes inflammation, reduces redness, and regulates melanin production, visibly diminishing dark spots and hyperpigmentation.
• Tranexamic acid — Inhibits UV-induced plasmin activity and tyrosinase, reducing pigmentation, brightening the skin, and fading dark spots.
• Resorcinol — Provides gentle exfoliation, promoting cellular renewal and surface rejuvenation.
• Glutathione — Brightens the complexion by converting melanin into a lighter form while also inhibiting tyrosinase.
• Arbutin — Works synergistically with tranexamic acid to inhibit tyrosinase, the key enzyme in melanin synthesis.